Takes Action Against Aeroclean Technologies
Seeking $20 Million in damages
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically, today
announced that its wholly-owned subsidiary, Sterilumen, Inc., has
filed a lawsuit in the amount of $20 million against Aeroclean
Technologies, Inc. (NASDAQ: AERC) and its predecessor, Aeroclean
Technologies, LLC, for trademark infringement, unfair competition
and damaging Sterilumen.
John F. Andrews, Applied UV’s CEO and Director, stated,
“Protecting our brand, Airoclean®, and trademarked products and
technologies is crucial, and we will vigorously defend against
infringements. Sterilumen is the owner of 29 issued patents and 18
pending patent applications and five ‘AIRO’ trademarks, including
Airoclean®, in 19 countries, all of which are for use in connection
with our air purification products. Significant resources have been
invested to develop the products, and we currently possess a number
of issued patents and pending patent applications with respect to
both the AIRO products and the related technologies. Our brand is
under attack by a new market entrant, Aeroclean, that improperly
adopted and began to use a mark in connection with its own air
purification products that we believe infringes on our trademark
rights, creates confusion for buyers and violates fair competition
practices.”
“This filing is an important effort to protect the good will
that has been created for our products and the trust that has been
built with our customers,” Andrews continued. “When an entity
purchases any of our ‘AIRO’ branded products they can be assured of
the science and technology that has gone into the products to make
them effective, safe and reliable.”
The Airocide™ system of air purification technologies was
originally developed for NASA with assistance from the University
of Wisconsin at Madison. It uses UVC energy to activate our
proprietary, titanium dioxide-based photocatalyst that oxidizes and
destroys all carbon-based molecules. This system has applications
in the hospitality, hotel, healthcare, nursing homes, grocer, wine,
commercial buildings and retail sectors. The Airocide™ system has
been used by brands and organizations such as NASA, Whole Foods,
Dole, Chiquita, Palace Vesace, Sub-Zero Refrigerators and Robert
Mondavi Wines.
The complaint has been filed in the U.S. District Court for the
Southern District of New York.
Follow us on Twitter Follow us on LinkedIn
About Applied UV
Applied UV is focused on the development and acquisition of
technology that address infection control in the healthcare,
hospitality, commercial and municipal markets. The Company has two
wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and
Munn Works, LLC (“Munn Works”). SteriLumen’s connected platform for
Data Driven Disinfection™ applies the power of ultraviolet light
(UVC) to destroy pathogens safely, thoroughly, and automatically,
addressing the challenge of healthcare-acquired infections
("HAIs"). Targeted for use in facilities that have high customer
turnover such as hospitals, hotels, commercial facilities, and
other public spaces, the Company’s Lumicide™ platform uses UVC LEDs
in several patented designs for infection control in and around
high-traffic areas, including sinks and restrooms, killing
bacteria, viruses, and other pathogens residing on hard surfaces
within devices’ proximity. The Company’s patented in-drain
disinfection device, Lumicide Drain, is the only product on the
market that addresses this critical pathogen intensive location.
SteriLumen’s Airocide® air purification devices are research
backed, clinically proven and developed for NASA with assistance
from the University of Wisconsin. Airocide® is listed as an FDA
Class II Medical device, utilizes a proprietary photocatalytic
(PCO) bioconversion technology that draws air into a reaction
chamber that converts damaging molds, microorganisms, dangerous
airborne pathogens, destructive VOCs, allergens, odors and
biological gasses into harmless water vapor and green carbon
dioxide without producing ozone or other harmful byproducts.
Airocide® applications include healthcare, hospitality, grocery
chains, wine making facilities, commercial real estate, schools,
dental offices, post-harvest, grocery, cannabis facilities and
homes. For more information about Applied UV, Inc., and its
subsidiaries, please visit the following websites:
https://www.applieduvinc.com/
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward‐looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward–looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward‐looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward‐looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward‐looking
statements to conform these statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220815005064/en/
Applied UV Inc. John F. Andrews Applied UV CEO, Director
john.andrews@applieduvinc.com Brett Maas, Managing Principal Hayden
IR brett@haydenir.com (646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Apr 2023 to Apr 2024